Insmed (INSM) Cash from Operations (2010 - 2026)
Insmed (INSM) recorded quarterly Cash from Operations of 222738000.0 in Q1 2026, up 10.04% quarter-over-quarter from 247596000.0 in Q4 2025, and up 15.01% on a YoY basis from 193661572.01 in Q1 2025.
Insmed (INSM) Cash from Operations (2010 - 2026) Analysis & Trends
Insmed's Cash from Operations history runs 17 years deep, the most recent figure standing at 222738000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 15.01% year-over-year to 222738000.0; the TTM figure through Mar 2026 stood at 895664000.0 (down 17.55% YoY), while the FY2025 annual figure was 935014000.0, down 36.72% from the prior year.
- Cash from Operations was 222738000.0 for Q1 2026 at Insmed, up from 247596000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 89828000.0 in Q3 2022 to a low of 262088000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 163430588.24 across 5 years, with a median of 146303000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations gained 18.02% in 2022, then tumbled 67.19% in 2025.
- A 5-year view of Cash from Operations shows it stood at 103149000.0 in 2022, then fell by 26.83% to 130819000.0 in 2023, then plunged by 49.81% to 195979000.0 in 2024, then declined by 26.34% to 247596000.0 in 2025, then gained by 10.04% to 222738000.0 in 2026.
- The last three Cash from Operations figures came in at 222738000.0 (Q1 2026), 247596000.0 (Q4 2025), and 219761000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -222.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -222.74 Mn |
| Mar 31, 2026 | -222.74 Mn |
| Dec 31, 2025 | -247.60 Mn |
| Dec 31, 2025 | -247.60 Mn |
| Sep 30, 2025 | -219.76 Mn |
| Sep 30, 2025 | -219.76 Mn |
| Jun 30, 2025 | -205.57 Mn |
| Jun 30, 2025 | -205.57 Mn |
| Mar 31, 2025 | -262.09 Mn |
| Mar 31, 2025 | -262.09 Mn |
| Dec 31, 2024 | -195.98 Mn |
| Dec 31, 2024 | -195.98 Mn |
| Sep 30, 2024 | -180.92 Mn |
| Sep 30, 2024 | -180.92 Mn |
| Jun 30, 2024 | -122.95 Mn |
| Jun 30, 2024 | -122.95 Mn |
| Mar 31, 2024 | -184.04 Mn |
| Mar 31, 2024 | -184.04 Mn |
| Dec 31, 2023 | -130.82 Mn |
| Dec 31, 2023 | -130.82 Mn |